These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 12915049)

  • 21. Data presentation in rodent stroke studies and the predictive value of confidence intervals.
    Sughrue ME; Grobelny BT; Ducruet AF; Komotar RJ; Mocco J; Sciacca RR; Sander Connolly E
    J Clin Neurosci; 2010 Jan; 17(1):11-5. PubMed ID: 19963387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NXY-059: review of neuroprotective potential for acute stroke.
    Fong JJ; Rhoney DH
    Ann Pharmacother; 2006 Mar; 40(3):461-71. PubMed ID: 16507608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials.
    Meissner W; Hill MP; Tison F; Gross CE; Bezard E
    Trends Pharmacol Sci; 2004 May; 25(5):249-53. PubMed ID: 15120490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lost in translation: taking neuroprotection from animal models to clinical trials.
    Hoyte L; Kaur J; Buchan AM
    Exp Neurol; 2004 Aug; 188(2):200-4. PubMed ID: 15246820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reprint: Good laboratory practice: preventing introduction of bias at the bench.
    Macleod MR; Fisher M; O'Collins V; Sena ES; Dirnagl U; Bath PM; Buchan A; van der Worp HB; Traystman RJ; Minematsu K; Donnan GA; Howells DW
    Int J Stroke; 2009 Feb; 4(1):3-5. PubMed ID: 19236488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cerebral ischemia--challenges and perspectives].
    Baron JC
    Therapie; 2002; 57(6):531-9. PubMed ID: 12666260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Translation: case study in failure.
    Johnston SC
    Ann Neurol; 2006 Mar; 59(3):447-8. PubMed ID: 16489618
    [No Abstract]   [Full Text] [Related]  

  • 28. Neuroprotection and stroke: time for a compromise.
    Young AR; Ali C; Duretête A; Vivien D
    J Neurochem; 2007 Nov; 103(4):1302-9. PubMed ID: 17727635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting the brain: neuroprotection and neurorestoration in ischemic stroke.
    Saver JL
    Pharmacotherapy; 2010 Jul; 30(7 Pt 2):62S-9S. PubMed ID: 20575624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombolysis and neuroprotection in cerebral ischemia.
    Gutiérrez M; Díez Tejedor E; Alonso de Leciñana M; Fuentes B; Carceller F; Roda JM
    Cerebrovasc Dis; 2006; 21 Suppl 2():118-26. PubMed ID: 16651822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IMAGES and FAST-MAG: magnesium for acute ischaemic stroke.
    Gorelick PB; Ruland S
    Lancet Neurol; 2004 Jun; 3(6):330. PubMed ID: 15157845
    [No Abstract]   [Full Text] [Related]  

  • 33. The only evidence based neuroprotective therapy for acute ischemic stroke: thrombolysis.
    Köhrmann M; Schellinger PD; Schwab S
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):563-71. PubMed ID: 21619867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ischemic penumbra: a new opportunity for neuroprotection.
    Fisher M
    Cerebrovasc Dis; 2006; 21 Suppl 2():64-70. PubMed ID: 16651816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of dipyridamole during acute stroke: exploring antithrombosis and neuroprotective benefits.
    d'Esterre CD; Lee TY
    Ann N Y Acad Sci; 2010 Oct; 1207():71-5. PubMed ID: 20955428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in pharmacologic neuroprotection.
    Mantz J; Degos V; Laigle C
    Eur J Anaesthesiol; 2010 Jan; 27(1):6-10. PubMed ID: 19617840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving the efficiency of the development of drugs for stroke.
    Howells DW; Sena ES; O'Collins V; Macleod MR
    Int J Stroke; 2012 Jul; 7(5):371-7. PubMed ID: 22712738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Citicoline--the first effective neuroprotectant to be combined with thrombolysis in acute ischemic stroke?
    Overgaard K; Meden P
    J Neurol Sci; 2006 Sep; 247(2):119-20. PubMed ID: 16765988
    [No Abstract]   [Full Text] [Related]  

  • 39. Translational Hurdles in Stroke Recovery Studies.
    Jolkkonen J; Kwakkel G
    Transl Stroke Res; 2016 Aug; 7(4):331-42. PubMed ID: 27000881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?
    De Keyser J; Sulter G; Luiten PG
    Trends Neurosci; 1999 Dec; 22(12):535-40. PubMed ID: 10542428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.